These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 9217704)

  • 1. Protective effect of Trypanosoma rangeli against infections with a highly virulent strain of Trypanosoma cruzi.
    Zuñiga C; Palau T; Penin P; Gamallo C; de Diego JA
    Trop Med Int Health; 1997 May; 2(5):482-7. PubMed ID: 9217704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
    Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
    Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection.
    Haolla FA; Claser C; de Alencar BC; Tzelepis F; de Vasconcelos JR; de Oliveira G; Silvério JC; Machado AV; Lannes-Vieira J; Bruna-Romero O; Gazzinelli RT; dos Santos RR; Soares MB; Rodrigues MM
    Vaccine; 2009 Sep; 27(41):5644-53. PubMed ID: 19635607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trypanosoma rangeli: epimastigote immunogenicity and cross-reaction with Trypanosoma cruzi.
    Saldaña A; Sousa OE
    J Parasitol; 1996 Apr; 82(2):363-6. PubMed ID: 8604121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient protective immunity against Trypanosoma cruzi infection after nasal vaccination with recombinant Sendai virus vector expressing amastigote surface protein-2.
    Duan X; Yonemitsu Y; Chou B; Yoshida K; Tanaka S; Hasegawa M; Tetsutani K; Ishida H; Himeno K; Hisaeda H
    Vaccine; 2009 Oct; 27(44):6154-9. PubMed ID: 19712768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with an engineered mutant trans-sialidase highly protects mice from experimental Trypanosoma cruzi infection: a vaccine candidate.
    Fontanella GH; De Vusser K; Laroy W; Daurelio L; Nocito AL; Revelli S; Contreras R
    Vaccine; 2008 May; 26(19):2322-34. PubMed ID: 18403070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccination with Trypanosoma rangeli induces resistance of guinea pigs to virulent Trypanosoma cruzi.
    Basso B; Moretti E; Fretes R
    Vet Immunol Immunopathol; 2014 Jan; 157(1-2):119-23. PubMed ID: 24275040
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody response to experimental Trypanosoma rangeli infection and its implications for immunodiagnosis of South American trypanosomiasis.
    Guhl F; Hudson L; Marinkelle CJ; Morgan SJ; Jaramillo C
    Acta Trop; 1985 Dec; 42(4):311-8. PubMed ID: 2868633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Experimental Chagas disease. Innate immune response in Balb/c mice previously vaccinated with Trypanosoma rangeli. I. The macrophage shows immunological memory: Reality or fiction?
    Basso B; Marini V
    Immunobiology; 2014 Apr; 219(4):275-84. PubMed ID: 24321621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Wild reservoirs and vectors of Trypanosoma cruzi. LXXIII: Resistance against wild strains of T. cruzi in mice inoculated with Herpetomas samuelpessoai].
    Belda Neto FM; Ribeiro RD; Barretto MP
    Rev Bras Biol; 1979 Mar; 39(1):209-14. PubMed ID: 111309
    [No Abstract]   [Full Text] [Related]  

  • 12. Action of Trypanosoma rangeli in infections with virulent Trypanosoma cruzi populations.
    Paláu MT; Mejía AJ; Vergara U; Zúñiga CA
    Mem Inst Oswaldo Cruz; 2003 Jun; 98(4):543-8. PubMed ID: 12937771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypanosoma cruzi: protective response of vaccinated mice is mediated by CD8+ cells, prevents signs of polyclonal T lymphocyte activation, and allows restoration of a resting immune state after challenge.
    Paiva CN; Castelo-Branco MT; Lannes-Vieira J; Gattass CR
    Exp Parasitol; 1999 Jan; 91(1):7-19. PubMed ID: 9920038
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic protection against Chagas disease. Independent effects upon infection, dissemination and lesions of Trypanosoma cruzi].
    Basombrio MA; Mora MC; Segura MA
    Medicina (B Aires); 1989; 49(3):191-6. PubMed ID: 2518641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Trypanosoma cruzi infection from the view of CD8+ T cell immunity--an infection model for developing T cell vaccine.
    Miyahira Y
    Parasitol Int; 2008 Mar; 57(1):38-48. PubMed ID: 17728174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination with epimastigotes of different strains of Trypanosoma rangeli protects mice against Trypanosoma cruzi infection.
    Basso B; Moretti E; Fretes R
    Mem Inst Oswaldo Cruz; 2008 Jun; 103(4):370-4. PubMed ID: 18660992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparative pathological study of three strains of Trypanosoma cruzi in an experimental model.
    de Diego JA; Penin P; del Rey J; Mayer R; Gamallo C
    Histol Histopathol; 1991 Apr; 6(2):199-206. PubMed ID: 1802119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American trypanosomosis: in situ and generalized features of parasitism and inflammation kinetics in a murine model.
    Monteón VM; Furuzawa-Carballeda J; Alejandre-Aguilar R; Aranda-Fraustro A; Rosales-Encina JL; Reyes PA
    Exp Parasitol; 1996 Aug; 83(3):267-74. PubMed ID: 8823243
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
    Basombrío MA; Segura MA; Nasser JR
    J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental Chagas' disease: I. Study of different immunization conditions in the infection course].
    Introini MV; Basso B; Moretti E
    Bol Chil Parasitol; 1998; 53(3-4):45-51. PubMed ID: 10413878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.